कृपया अन्य खोज का प्रयास करें
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) that is in Phase 1/2 and 2 clinical trials to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002 for the treatment of type 1 diabetes, and GPX-003 for the treatment of type 2 diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Shu Kam Mok | 62 | - | Member of Scientific & Medical Advisory Board |
Pasi Antero Janne | - | - | Member of Scientific & Medical Advisory Board |
George Simon | - | - | Member of Scientific & Medical Advisory Board |
John Rodney Varner | 66 | 2012 | Co-Founder, Chairman, President & CEO |
Brent M. Longnecker | 67 | 2020 | Independent Director |
George K. Gittes | - | 2020 | Member of Scientific Advisory Board |
Jose Antonio Moreno Toscano | 50 | 2020 | Independent Director |
Michael Morse | - | 2021 | Member of Clinical Advisory Board |
James E. Rothman | 72 | 2012 | Strategic Advisor to the Board of Directors |
William R. Wilson | 73 | 2020 | Independent Director |
Andrew B. Becker | - | 2021 | Member of Clinical Advisory Board |
George E. Peoples | - | 2021 | Member of Clinical Advisory Board |
Jack A. Roth | - | - | Chairman of Scientific & Medical Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है